Insider · CIK 0001233840
LAMPERT MARK N
Reports to the SEC for 59 companies · SAN FRANCISCO, CA
Transactions
5
Companies
59
Filings
2
CIK
0001233840
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2016-06-23 | Cascadian Therapeutics, Inc.Series D Convertible Preferred StockA Award | +$4.4M |
| 2016-06-23 | Cascadian Therapeutics, Inc.Series D Convertible Preferred StockA Award | +$3.62M |
| 2016-06-23 | Cascadian Therapeutics, Inc.Series D Convertible Preferred StockA Award | +$823K |
| 2016-06-23 | Cascadian Therapeutics, Inc.Series D Convertible Preferred StockA Award | +$4.96M |
| 2003-10-17 | ARENA PHARMACEUTICALS INCS Sale | −$22.4M |
Recent filings
- 4Cascadian Therapeutics, Inc.0000921895-16-005018SEC(opens sec.gov)
- 4LAMPERT MARK N0001055947-03-000026SEC(opens sec.gov)
Companies
- 4D Molecular Therapeutics, Inc.See Explanation of ResponsesFDMT
- ABBOTT BIOTHERAPEUTICS CORP10% Owner
- ADOLOR CORP10% Owner
- Allakos Inc.10% Owner
- ALPINE IMMUNE SCIENCES, INC.10% Owner
- ARENA PHARMACEUTICALS INCDirector, 10% Owner
- ARQULE INC10% Owner
- ARRAY BIOPHARMA INCSee Explanation of Responses
- Astex Pharmaceuticals, Inc10% Owner
- AVIGEN INC \DE10% Owner
- Calithera Biosciences, Inc.10% Owner
- Capstone Holding Corp.See Explanation of ResponsesCAPS
- Cascadian Therapeutics, Inc.Director, 10% Owner
- Celera CORP10% Owner
- ChemoCentryx, Inc.See Explanation of Responses
- CONCERT PHARMACEUTICALS, INC.10% Owner
- CRESCENT BIOPHARMA, INC.10% OwnerCBIO
- CTI BIOPHARMA CORPDirector, 10% Owner, See Explanation of Responses
- Cullinan Therapeutics, Inc.10% OwnerCGEM
- CYTOKINETICS INCSee Explanation of ResponsesCYTK
- CytomX Therapeutics, Inc.See Explanation of ResponsesCTMX
- DYNAVAX TECHNOLOGIES CORP10% OwnerDVAX
- Eledon Pharmaceuticals, Inc.10% OwnerELDN
- enGene Therapeutics Inc.10% OwnerENGN
- EPIRUS Biopharmaceuticals, Inc.10% Owner
- ESSA Pharma Inc.10% OwnerEPIX
- FIVE PRIME THERAPEUTICS, INC.10% Owner
- Foghorn Therapeutics Inc.10% OwnerFHTX
- GYRE THERAPEUTICS, INC.See Explanation of ResponsesGYRE
- ICAGEN INC10% Owner
- IDEAYA Biosciences, Inc.See Explanation of ResponsesIDYA
- IMMUNE DESIGN CORP.10% Owner
- IMMUNIC, INC.Director, See Explanation of ResponsesIMUX
- INFINITY PHARMACEUTICALS, INC.See Explanation of Responses
- KENT INTERNATIONAL HOLDINGS INCSee Explanation of Responses
- Kymera Therapeutics, Inc.Director, See Remarks and FootnotesKYMR
- LIGAND PHARMACEUTICALS INCSee Explanation of ResponsesLGND
- MEDICINOVA INC10% OwnerMNOV
- Merus N.V.10% OwnerMRUS
- MoonLake ImmunotherapeuticsDirector, 10% OwnerMLTX
- NEUROBIOLOGICAL TECHNOLOGIES INC /CA/10% Owner
- NEUROCRINE BIOSCIENCES INCSee Explanation of ResponsesNBIX
- Olema Pharmaceuticals, Inc.Director, See Explanation of ResponsesOLMA
- PALATIN TECHNOLOGIES INC10% OwnerPTN
- PALVELLA THERAPEUTICS, INC.See Explanation of ResponsesPVLA
- POINT Biopharma Global Inc.Former 10% Owner
- Principia Biopharma Inc.10% Owner
- Rain Oncology Inc.Director, See Remarks; Former 10% Owner
- Regulus Therapeutics Inc.10% Owner
- Repare Therapeutics Inc.10% OwnerRPTX
- REPLIGEN CORP10% Owner, Indirect Beneficial OwnerRGEN
- RIGEL PHARMACEUTICALS INC10% OwnerRIGL
- Structure Therapeutics Inc.10% OwnerGPCR
- Syndax Pharmaceuticals Inc10% OwnerSNDX
- Third Harmonic Bio, Inc.See Explanation of Responses
- Tobira Therapeutics, Inc.See Explanation of Responses
- Verastem, Inc.10% OwnerVSTM
- Xenon Pharmaceuticals Inc.10% OwnerXENE
- XOMA Royalty Corp10% Owner
Address
44 MONTGOMERY ST. 40TH FLOOR
SAN FRANCISCO, CA, 94104